Industry News
Drastic cost-cutting at Benitec
Benitec retrenches staff to reduce cash burn [ + ]
AH&MRC profile: Mike McGuckin
Who would have thought that a few incontinent mice dubbed Winnie and Eeyore could reveal a whole new way of thinking about and possibly treating inflammatory bowel disease in humans? [ + ]
Xenome gets acute
Xenome licenses IP for acute pancreatitis peptides [ + ]
Zebra fish research facility opens at Monash
The largest zebra fish research facility in the Southern Hemisphere has been opened at Monash University. One of the key areas of research will be in determining how muscles grow and develop.
[ + ]AH&MRC profile: Helen Ball
The pathophysiology of the IDOs [ + ]
Byrne burns big at Monash
Ed Byrne replaces Richard Larkins as Monash VC, zebra fish facility opens [ + ]
Cancer drugs reverse diabetes in mice
Tyrosine kinase inhibitors reverse type 1 diabetes in mice [ + ]
Cytopia zeroes in on brain
Cytopia commences efficacy trial dosing for VDA in brain cancer [ + ]
Asian flu study a MARVEL
Biota’s next-generation flu treatment moves into Phase III [ + ]
AH&MRC profile: Elaine Fuchs
The Australian Health & Medical Research Congress started today in Brisbane. We kick off proceedings by profiling renowned adult stem cell researcher, Elaine Fuchs. [ + ]
PEA and cancer cell self-cannibalisation
US researchers find protein induces autophagy in ovarian cancer [ + ]
Strains and sprains for Phosphagenics
Phosphagenics opens Phase I trial of topical NSAID for inflammation [ + ]
Alzheimer’s disease breakthrough
Scientists working within CSIRO’s Preventative Health Flagship have discovered a rapid screening system to identify inhibitors of toxic multimer formation which is implicated in Alzheimer’s disease progression. It is hoped that this may lead to the discovery of new agents which may prove useful in preventing or delaying the onset of the disease.
[ + ]Biotech briefs
Phosphagenics, Patrys, Novogen, Stem Cell Sciences, Mesoblast [ + ]